MARKET NEWS

Cambrex to Double Size of Edinburgh Solid Form Screening Facility
Mino-Wrap to be Developed Through an IND Process
Principia Announces Update to Ongoing Phase 2 Clinical Trial
MariMed Signs Multi-State Licensing Agreement
Foamix Announces $64-Million Capital Financing Investment by Perceptive Advisors & OrbiMed
PROMETRIKA Partners With Comprehend to Enhance its Full-Service Clinical Trial Offering

  FEATURED EDITORIAL

  COMPANY PROFILE

Founded in 1897, BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety, and expand access to healthcare. BD’s drug delivery systems are designed to protect, package, and deliver drug therapies and to maximize healthcare worker and patient safety. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Atlas Nanotech Opens First Revenue Stream With Gem Labs Contract

Atlas Nanotech Opens First Revenue Stream With Gem Labs Contract

The contract calls for Atlas to sell stabilized and functionalized silver nanoparticles to Gem Labs for use in the manufacture of one of Gem Labs proprietary products.

LabTwin Partners With  Bonneville Labs & Lab Launch to Give Biotech Startups Access to World’s First Voice & AI-Powered Digital Lab Assistant

LabTwin Partners With  Bonneville Labs & Lab Launch to Give Biotech Startups Access to World’s First Voice & AI-Powered Digital Lab Assistant

LabTwin GmbH, the world’s first voice and AI-powered digital lab assistant, recently announced partnerships with CA-based life science shared lab facilities Bonneville Labs and Lab Launch to……

Quotient Sciences to Recapitalize With Global Private Equity Firm

Quotient Sciences to Recapitalize With Global Private Equity Firm

Quotient Sciences and global investment firm Permira recently announced that a company backed by the Permira Funds has signed a definitive agreement to acquire a majority stake in…….

Pfenex & Arcellx Announce Development, Evaluation & License Agreement

Pfenex & Arcellx Announce Development, Evaluation & License Agreement

Pfenex Inc. and Arcellx, Inc. recently announced a Development, Evaluation, and License agreement under which Arcellx gains access to the proprietary Pfenex Expression Technology platform to advance……

Creating Your Secondary Packaging Strategy - Begin With the End in Mind

Creating Your Secondary Packaging Strategy - Begin With the End in Mind

Whether it is meeting the needs of a rapidly aging market, blocking drug counterfeiters, or differentiating your pharmaceutical product in the market, a secondary packaging program is an important factor in………

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

August 14 – Analytical Testing
August 21 – ODT/Fast Dissolve